- Home
- TDUP vs GPCR Comparison
TDUP vs GPCR Comparison
Compare TDUP & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDUP
- GPCR
- Stock Information
- Founded
- TDUP 2009
- GPCR 2016
- Country
- TDUP United States
- GPCR United States
- Employees
- TDUP N/A
- GPCR N/A
- Industry
- TDUP Catalog/Specialty Distribution
- GPCR
- Sector
- TDUP Consumer Discretionary
- GPCR
- Exchange
- TDUP Nasdaq
- GPCR Nasdaq
- Market Cap
- TDUP 1.3B
- GPCR 1.2B
- IPO Year
- TDUP 2021
- GPCR 2023
- Fundamental
- Price
- TDUP $9.45
- GPCR $24.89
- Analyst Decision
- TDUP Buy
- GPCR Strong Buy
- Analyst Count
- TDUP 3
- GPCR 8
- Target Price
- TDUP $12.50
- GPCR $69.57
- AVG Volume (30 Days)
- TDUP 2.3M
- GPCR 1.3M
- Earning Date
- TDUP 11-03-2025
- GPCR 11-12-2025
- Dividend Yield
- TDUP N/A
- GPCR N/A
- EPS Growth
- TDUP N/A
- GPCR N/A
- EPS
- TDUP N/A
- GPCR N/A
- Revenue
- TDUP $277,729,000.00
- GPCR N/A
- Revenue This Year
- TDUP $17.99
- GPCR N/A
- Revenue Next Year
- TDUP $9.68
- GPCR N/A
- P/E Ratio
- TDUP N/A
- GPCR N/A
- Revenue Growth
- TDUP 20.14
- GPCR N/A
- 52 Week Low
- TDUP $0.50
- GPCR $13.22
- 52 Week High
- TDUP $12.28
- GPCR $44.79
- Technical
- Relative Strength Index (RSI)
- TDUP 40.39
- GPCR 67.89
- Support Level
- TDUP $9.08
- GPCR $23.61
- Resistance Level
- TDUP $10.83
- GPCR $26.15
- Average True Range (ATR)
- TDUP 0.43
- GPCR 1.32
- MACD
- TDUP -0.22
- GPCR 0.28
- Stochastic Oscillator
- TDUP 17.75
- GPCR 79.38
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.